|
Market Closed -
Other stock markets
|
After hours 01:00:00 | |||
| 3.850 USD | -8.11% |
|
4.250 | +10.39% |
| Market Cap | 223M 194M 180M 166M 313M 21.28B 318M 2.13B 835M 10.6B 837M 819M 35.53B | P/E 2026 * |
-2.88x | P/E 2027 * | -2.76x |
|---|---|---|---|---|---|
| Enterprise Value | 223M 194M 180M 166M 313M 21.28B 318M 2.13B 835M 10.6B 837M 819M 35.53B | EV / Sales 2026 * |
3.1x | EV / Sales 2027 * | 4.15x |
| Free-Float |
90.53% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Capricor Therapeutics, Inc.
| 1 day | -8.11% | ||
| 1 week | -80.46% | ||
| 1 month | -84.01% | ||
| 3 months | -88.53% | ||
| 6 months | -82.41% | ||
| Current year | -86.66% |
| 1 week | 2.96 |  | 7.85 |
| 1 month | 2.96 | | 24.57 |
| Current year | 2.96 | | 36.82 |
| 1 year | 2.96 | | 40.37 |
| 3 years | 2.68 | | 40.37 |
| 5 years | 2.56 | | 40.37 |
| 10 years | 0.88 | | 42.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Linda Marbán
CEO | Chief Executive Officer | 62 | 19/11/2013 |
Anthony Bergmann
DFI | Director of Finance/CFO | 40 | 31/12/2017 |
Michael Binks
CTO | Chief Tech/Sci/R&D Officer | - | 12/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Frank Litvack
CHM | Chairman | 70 | 31/10/2013 |
David Musket
BRD | Director/Board Member | 68 | 19/11/2013 |
George Dunbar
BRD | Director/Board Member | 79 | 19/11/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02/04/26 | Fiscal year | Director | 22,587 | 0.0393% | ||
| 05/01/26 | Free | General Counsel | 45,000 | 0.0827% | ||
| 05/01/26 | Free | Director | 15,500 | 0.0285% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.11% | -80.46% | -52.93% | -12.50% | 223M | |
| +2.35% | +2.74% | +33.41% | +79.20% | 56.54B | |
| -0.21% | -7.38% | +25.34% | +63.02% | 53.6B | |
| -2.44% | +1.40% | -15.74% | -16.80% | 22.91B | |
| -2.85% | -7.78% | -8.09% | +346.36% | 21.37B | |
| +2.49% | -0.92% | +20.31% | -12.15% | 20.27B | |
| +0.79% | -1.06% | +29.29% | -33.32% | 17.56B | |
| +0.58% | -5.88% | +16.30% | +540.37% | 14.75B | |
| -5.25% | -4.23% | +46.41% | +169.05% | 13.33B | |
| +3.41% | -6.61% | +163.08% | +280.43% | 13.53B | |
| Average | -0.92% | -11.46% | +25.74% | +140.36% | 23.41B | |
| Weighted average by Cap. | +0.22% | -3.03% | +28.59% | +119.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 71.95M 62.55M 58.22M 53.45M 101M 6.87B 103M 686M 269M 3.42B 270M 264M 11.47B | 53.75M 46.73M 43.49M 39.93M 75.41M 5.13B 76.58M 513M 201M 2.55B 202M 197M 8.57B |
| Net income | -82.36M -71.6M -66.64M -61.19M -116M -7.86B -117M -786M -308M -3.91B -309M -303M -13.13B | -83.73M -72.78M -67.75M -62.2M -117M -7.99B -119M -799M -313M -3.98B -314M -308M -13.34B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | US$3.850 | -8.11% | 7,297,140 |
| 30/07/26 | US$4.190 | -36.23% | 28,916,937 |
| 28/07/26 | US$6.570 | -6.08% | 16,545,728 |
| 27/07/26 | US$6.995 | -64.49% | 29,995,425 |
| 24/07/26 | US$19.70 | -0.66% | 2,469,814 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CAPR Stock
Select your edition
All financial news and data tailored to specific country editions
